TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26494856

Group type: EXPERIMENTAL
Intervention: High-dose FOLFIRI plus bevacizumab (every 2 weeks) in group 1 (UGT1A1 *1/*1)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: High-dose FOLFIRI plus bevacizumab (every 2 weeks) in group 2 (UGT1A1 *1/*28)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: High-dose FOLFIRI plus bevacizumab (overall population)
Number of subjects: 86
Study: 24494468

Group type: EXPERIMENTAL
Intervention: Restrictive group (RG) with low range of ITBVI (600‐800 ml/m2)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Liberal group (LG) with normal ITBVI (800‐1000 ml/m2)
Number of subjects: 22
Study: 21272714

Group type: EXPERIMENTAL
Intervention: Dorsal padded aluminum splint
Number of subjects: 64

Group type: COMPARATOR
Intervention: Stack splint (control)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Custom-made thermoplastic thimble splint
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: All splint types
Number of subjects: 64
Study: 20209995

Group type: EXPERIMENTAL
Intervention: Balanced crystalloid solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unbalanced crystalloid solution
Number of subjects: 0
Study: 16377095

Group type: EXPERIMENTAL
Intervention: Shorter AR CAG repeat polymorphisms (<17) in violent criminals
Number of subjects: 254

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 254
Study: 14742364

Group type: EXPERIMENTAL
Intervention: Preemptive great auricular nerve block (GAN-block) with 0.25% bupivacaine with 1:200,000 epinephrine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Preemptive great auricular nerve block with normal saline (sham block)
Number of subjects: 40
Study: 11730815

Group type: COMPARATOR
Intervention: CEE+MPA
Number of subjects: 105

Group type: COMPARATOR
Intervention: Tibolone
Number of subjects: 105

Group type: COMPARATOR
Intervention: Nitroglycerine induced dilatation
Number of subjects: 105
Study: 9229214

Group type: COMPARATOR
Intervention: Diet records
Number of subjects: 101

Group type: COMPARATOR
Intervention: Food frequency questionnaires
Number of subjects: 101

Group type: COMPARATOR
Intervention: Modules (brief food frequency questionnaires)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Modules
Number of subjects: 101

Group type: COMPARATOR
Intervention: All methods
Number of subjects: 101
Study: 7525694

Group type: EXPERIMENTAL
Intervention: Interferon-alpha therapy (recombinant interferon-alpha 2a)
Number of subjects: 55
Study: 3593452

Group type: EXPERIMENTAL
Intervention: Zotepine (100 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Moclobemide (200 mg)
Number of subjects: 30
Study: 29508020

Group type: EXPERIMENTAL
Intervention: Venoplant tablets and Venoplant gel
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Only Venoplant tablets
Number of subjects: 43

Group type: COMPARATOR
Intervention: Not treated with Venoplant
Number of subjects: 43
Study: 27163717

Group type: EXPERIMENTAL
Intervention: 500ppm F plus 1% TMP (500TMP)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: 500ppm F plus 0.25% CaGP (500CaGP)
Number of subjects: 600

Group type: COMPARATOR
Intervention: 1100ppm F (1100F)
Number of subjects: 600
Study: 24924800

Group type: EXPERIMENTAL
Intervention: d-cycloserine (250 mg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 22884641

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 20211002

Group type: EXPERIMENTAL
Intervention: Indacaterol 150 microg once-daily
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 18596108

Group type: EXPERIMENTAL
Intervention: GLP‐1‐(7‐36) amide
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Yohimbine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: l‐NMMA
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 48
Study: 15667544

Group type: EXPERIMENTAL
Intervention: 4.5% albumin
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 0.9% saline
Number of subjects: 58

Group type: COMPARATOR
Intervention: Maintenance only (control)
Number of subjects: 58
Study: 11568777

Group type: EXPERIMENTAL
Intervention: Raloxifene 150 mg daily
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Continuous combined hormone replacement therapy (ccHRT)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 9760819

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) patients
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nondialyzed patients
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All patients (HD and nondialyzed)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 50
Study: 8311206

Group type: EXPERIMENTAL
Intervention: Nitrous oxide uptake during spontaneous ventilation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nitrous oxide uptake during controlled ventilation
Number of subjects: 40
Study: 2449062

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 30295296

Group type: EXPERIMENTAL
Intervention: Post-dinner moderate-intensity exercise (20 minutes on a treadmill, heart rate reserve of 40%)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (non-exercise condition)
Number of subjects: 29
Study: 27811949

Group type: EXPERIMENTAL
Intervention: Intraileal protein infusion (15 g over 60 min)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intraileal protein infusion
Number of subjects: 14

Group type: COMPARATOR
Intervention: Intraduodenal protein infusion
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 14

Group type: COMPARATOR
Intervention: Jejunal protein infusion
Number of subjects: 14
Study: 23879783

Group type: EXPERIMENTAL
Intervention: Enhanced physical education program
Number of subjects: 396

Group type: COMPARATOR
Intervention: Traditional physical education program
Number of subjects: 396
Study: 21824950

Group type: EXPERIMENTAL
Intervention: Soy isoflavone tablets, 200 mg daily
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study: 19909027

Group type: EXPERIMENTAL
Intervention: Outcome-based educational intervention on rational prescribing
Number of subjects: 112

Group type: COMPARATOR
Intervention: Traditional CME program on rational prescribing
Number of subjects: 112
Study: 17129981

Group type: EXPERIMENTAL
Intervention: Average LDL particle size below the median (261.2 Angstrom)
Number of subjects: 176

Group type: COMPARATOR
Intervention: LDL particle size above the median (261.2 Angstrom)
Number of subjects: 176
Study: 15612958

Group type: EXPERIMENTAL
Intervention: Extrathoracic expiratory resistance (EER; 0.89 kPa/L s at a flow of 0.5 L/s)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: COPD patients
Number of subjects: 31
Study: 11689035

Group type: EXPERIMENTAL
Intervention: Configural and featural cues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated exposure and experimenter feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Superfluous paraphernalia (hat)
Number of subjects: 0
Study: 9550501

Group type: EXPERIMENTAL
Intervention: Aggressive lipid-lowering therapy with statins
Number of subjects: 1351

Group type: COMPARATOR
Intervention: Moderate lipid-lowering therapy
Number of subjects: 1351
Study: 7942651

Group type: EXPERIMENTAL
Intervention: Arch wire adjustment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo adjustment
Number of subjects: 22
Study: 3191894

Group type: EXPERIMENTAL
Intervention: Progabide
Number of subjects: 95
Study: 31236643

Group type: EXPERIMENTAL
Intervention: Cocoa flavanols (900 mg CF)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (15 mg CF)
Number of subjects: 11
Study: 27688295

Group type: EXPERIMENTAL
Intervention: Information and request for consent for biospecimen and data sharing by the patient's physician
Number of subjects: 140

Group type: COMPARATOR
Intervention: Information and request for consent for biospecimen and data sharing by a research assistant
Number of subjects: 140
Study: 26556082

Group type: EXPERIMENTAL
Intervention: Conventional treatment group + visual spatial attention (optokinetic stimulation and right half‐field eye patching)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Conventional treatment group (only conventional rehabilitation training)
Number of subjects: 9
Study: 24236380

Group type: EXPERIMENTAL
Intervention: Female threat condition
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Male threat condition
Number of subjects: 161

Group type: COMPARATOR
Intervention: No threat condition
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Somatic anxiety
Number of subjects: 161
Study: 21218282

Group type: EXPERIMENTAL
Intervention: Assistance in obtaining dental care
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Stable housing, more than a high school education, and received help in getting dental care
Number of subjects: 593

Group type: COMPARATOR
Intervention: Black respondents
Number of subjects: 593

Group type: COMPARATOR
Intervention: Availability of dental services for low-income HIV-positive persons
Number of subjects: 593
Study: 19221130

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention including a general medical assessment and specific fall risk evaluation tool applied by a multidisciplinary fall prevention team
Number of subjects: 518

Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 518
Study: 22472671

Group type: EXPERIMENTAL
Intervention: Abdominal massage
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no abdominal massage)
Number of subjects: 80
Study: 15673377

Group type: EXPERIMENTAL
Intervention: AF patients
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: AF patients with hypertension
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: AF patients with left ventricular hypertrophy
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control patients with hypertension
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Persistent AF patients
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Persistent AF
Number of subjects: 124
Study: 12860586

Group type: EXPERIMENTAL
Intervention: Test-and-treat strategy by H pylori serology
Number of subjects: 270

Group type: COMPARATOR
Intervention: Endoscopy with Helicobacter pylori testing
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Test-and-treat strategy
Number of subjects: 270

Group type: COMPARATOR
Intervention: Endoscopy group
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Test-and-treat group
Number of subjects: 270
Study: 10215812

Group type: EXPERIMENTAL
Intervention: End-to-end anastomosis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Side-to-side anastomosis
Number of subjects: 100
Study: 8545170

Group type: EXPERIMENTAL
Intervention: Exercise-induced bronchoconstriction
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Histamine-induced bronchoconstriction
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Exercise-induced bronchoconstriction in older age group (11-12 years, n = 5)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Exercise-induced bronchoconstriction in younger age group (7-10 years, n = 9)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Histamine-induced bronchoconstriction in older age group (11-12 years, n = 5)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Histamine-induced bronchoconstriction in younger age group (7-10 years, n = 9)
Number of subjects: 14
Study: 2548222

Group type: EXPERIMENTAL
Intervention: Clonidine (0.2 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 1269192

Group type: EXPERIMENTAL
Intervention: Intravenous acebutolol (1 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral acebutolol (3 X 100 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Renal clearance of acebutolol (after intravenous dosing)
Number of subjects: 6
Study: 30832766

Group type: EXPERIMENTAL
Intervention: Muscle fatigue induced by physical exertion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Altering motor cortex function
Number of subjects: 0
Study: 27373976

Group type: EXPERIMENTAL
Intervention: 0.05 mmol/kg body weight of gadobenate dimeglumine (MultiHance)
Number of subjects: 65

Group type: COMPARATOR
Intervention: 0.1 mmol/kg body weight of gadoterate meglumine (Dotarem)
Number of subjects: 65
Study: 26304663

Group type: EXPERIMENTAL
Intervention: CABG plus medical therapy
Number of subjects: 2136

Group type: EXPERIMENTAL
Intervention: CABG with surgical ventricular reconstruction
Number of subjects: 2136

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 2136
Study: 23488859

Group type: EXPERIMENTAL
Intervention: Self-management programme (12-week duration)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 93
Study: 21515998

Group type: EXPERIMENTAL
Intervention: e-Learning program for operating room nursing
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no e-Learning program)
Number of subjects: 74
Study: 18813941

Group type: EXPERIMENTAL
Intervention: 6% carbohydrate electrolyte solution (CHO)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo drink (PLA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both CHO and PLA
Number of subjects: 12
Study: 16542576

Group type: EXPERIMENTAL
Intervention: Enoxaparin (1 mg/kg, q12 h) before catheterization
Number of subjects: 966

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH 25 mg intravenously before coronary angiography, additional 65 mg if PCI performed)
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 966

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 966
Study: 14499421

Group type: EXPERIMENTAL
Intervention: Intrathecal adenosine, 2 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Intravenous adenosine, 2 mg
Number of subjects: 7
Study: 10709052

Group type: EXPERIMENTAL
Intervention: Gore-tex graft
Number of subjects: 240

Group type: COMPARATOR
Intervention: Hemashield graft
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Patients younger than 65 years
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Grafts with diameter less than 7 mm
Number of subjects: 240
Study: 9314644

Group type: EXPERIMENTAL
Intervention: 30/70 IA (insulin aspart)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 30/70 HI (human insulin)
Number of subjects: 24
Study: 1549026

Group type: EXPERIMENTAL
Intervention: Liquid glucose (G)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Refined hot cereal (R)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Refined hot cereal with water-soluble fiber (R/F)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Oat bar (O)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 5
Study: 3900856

Group type: EXPERIMENTAL
Intervention: Oral carbamazepine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29991121

Group type: EXPERIMENTAL
Intervention: Standard rehabilitation plus mattress overlay use
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard rehabilitation only
Number of subjects: 38
Study: 28830541

Group type: EXPERIMENTAL
Intervention: Platycodon grandiflorum granules
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo granules
Number of subjects: 120
Study: 26303347

Group type: EXPERIMENTAL
Intervention: Tailored social cognitive intervention (SC) using a '5 As'-based personal action planning tool
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Combined intervention of both ENV and SC approaches (COMBO)
Number of subjects: 452

Group type: COMPARATOR
Intervention: Matched contact nutrition control (CON)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Increased environmental accessibility to PA resources via the provision of a free voucher to a fitness facility (ENV)
Number of subjects: 452
Study: 23247712

Group type: EXPERIMENTAL
Intervention: Modified Kaatsu training (CUFF) with three sets of 15 repetitions of unilateral biceps and triceps exercises, three times per week for 8 weeks.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonexercise control (CON) group wearing the cuff on one arm for a comparable amount of time.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: EX group compliance
Number of subjects: 40

Group type: COMPARATOR
Intervention: CON group compliance
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Perceived exertion and sensations during workouts using visual analog scales.
Number of subjects: 40
Study: 21308882

Group type: EXPERIMENTAL
Intervention: SSRI
Number of subjects: 291

Group type: COMPARATOR
Intervention: IPT
Number of subjects: 291
Study: 18085337

Group type: EXPERIMENTAL
Intervention: Spasm-controlled group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fissure apex group
Number of subjects: 0
Study: 16533239

Group type: EXPERIMENTAL
Intervention: 0.25% miconazole nitrate paste
Number of subjects: 40

Group type: COMPARATOR
Intervention: Unmedicated paste
Number of subjects: 40
Study: 14743985

Group type: EXPERIMENTAL
Intervention: NMES 3 times per week
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: NMES 2 times per week
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no electrical stimulation)
Number of subjects: 27
Study: 11235728

Group type: EXPERIMENTAL
Intervention: Conventional UF during bypass + venovenous MUF after bypass
Number of subjects: 40

Group type: COMPARATOR
Intervention: No UF
Number of subjects: 40
Study: 9774816

Group type: EXPERIMENTAL
Intervention: Outpatient neurological care
Number of subjects: 954

Group type: COMPARATOR
Intervention: Primary care referrals
Number of subjects: 954
Study: 7523736

Group type: EXPERIMENTAL
Intervention: Radical prostatectomy with early intervention for disease persistence/recurrence
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Expectant management with palliative therapy reserved for symptomatic or metastatic disease progression
Number of subjects: 2000
Study: 3357987

Group type: EXPERIMENTAL
Intervention: Thallium-201 myocardial scintigraphy (M)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Exercise radionuclide ventriculography (ERV)
Number of subjects: 23
Study: 31880084

Group type: EXPERIMENTAL
Intervention: Percutaneous robot‐assisted minimally invasive pedicle screw insertion
Number of subjects: 80

Group type: COMPARATOR
Intervention: Freehand fluoroscopy‐assisted pedicle screw insertion using a traditional open technique
Number of subjects: 80
Study: 29866086

Group type: EXPERIMENTAL
Intervention: HF‐rTMS (10 sessions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo/sham HF‐rTMS (10 sessions)
Number of subjects: 80
Study: 28107894

Group type: EXPERIMENTAL
Intervention: Heart rate variability biofeedback therapy (HRV-BF)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Graded exercise training (GET)
Number of subjects: 28
Study: 25160533

Group type: EXPERIMENTAL
Intervention: Lutein 10 mg daily for 1 year
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 22365647

Group type: EXPERIMENTAL
Intervention: B vitamins
Number of subjects: 1863

Group type: EXPERIMENTAL
Intervention: n‐3 PUFA
Number of subjects: 1863
Study: 21248246

Group type: EXPERIMENTAL
Intervention: Steerable sheath
Number of subjects: 130

Group type: COMPARATOR
Intervention: Nonsteerable sheath
Number of subjects: 130
Study: 18420965

Group type: EXPERIMENTAL
Intervention: Methacholine challenges
Number of subjects: 1041

Group type: EXPERIMENTAL
Intervention: History of hay fever
Number of subjects: 1041

Group type: EXPERIMENTAL
Intervention: Respiratory allergy
Number of subjects: 1041

Group type: EXPERIMENTAL
Intervention: Recent inhaled corticosteroid usage
Number of subjects: 1041
Study: 16085300

Group type: EXPERIMENTAL
Intervention: Primitives of Binding framework
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reflexivity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Government and Binding
Number of subjects: 0
Study: 12832707

Group type: EXPERIMENTAL
Intervention: S100A12 levels in serum and synovial fluid
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: S100A12 levels in patients with active arthritis
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: S100A12 expression in inflamed synovial tissue
Number of subjects: 42
Study: 10596755

Group type: EXPERIMENTAL
Intervention: MEP TAB9 with Montanide ISA720 adjuvant
Number of subjects: 100
Study: 8726593

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 0
Study: 1758385

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins (IVIG, 500 mg/kg Sandoglobulin)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Saline as placebo
Number of subjects: 58
Study: 6806473

Group type: EXPERIMENTAL
Intervention: Lack anaesthetic breathing system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Magill anaesthetic breathing system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bain anaesthetic breathing system
Number of subjects: 20
Study: 31881702

Group type: EXPERIMENTAL
Intervention: 30 g of walnuts per day
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 13
Study: 28917947

Group type: EXPERIMENTAL
Intervention: High glycemic load meal + caffeine capsules (3mgkg‐1 body weight)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High glycemic load meal + placebo capsules
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low glycemic load meal + placebo capsules
Number of subjects: 10
Study: 26335088

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing Therapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Brief Eclectic Psychotherapy (Cognitive-Behavioral Intervention)
Number of subjects: 140
Study: 23245520

Group type: EXPERIMENTAL
Intervention: Rigid fixation
Number of subjects: 1125

Group type: COMPARATOR
Intervention: Nonrigid fixation
Number of subjects: 1125
Study: 21346183

Group type: EXPERIMENTAL
Intervention: Intensive glycemic control
Number of subjects: 2053

Group type: COMPARATOR
Intervention: Standard glycemic control
Number of subjects: 2053